[Q63-Q85] Updated CIC Dumps PDF - CIC Real Valid Brain Dumps With 174 Questions!

Share

Updated CIC Dumps PDF - CIC Real Valid Brain Dumps With 174 Questions!

100% Free CIC Exam Dumps Use Real Infection Control Dumps

NEW QUESTION # 63
Which water type is suitable for drinking yet may still be a risk for disease transmission?

  • A. Grey water
  • B. Potable water
  • C. Purified water
  • D. Distilled water

Answer: B

Explanation:
To determine which water type is suitable for drinking yet may still pose a risk for disease transmission, we need to evaluate each option based on its definition, treatment process, and potential for contamination, aligning with infection control principles as outlined by the Certification Board of Infection Control and Epidemiology (CBIC).
* A. Purified water: Purified water undergoes a rigorous treatment process (e.g., reverse osmosis, distillation, or deionization) to remove impurities, contaminants, and microorganisms. This results in water that is generally safe for drinking and has a very low risk of disease transmission when properly handled and stored. However, if the purification process is compromised or if contamination occurs post-purification (e.g., due to improper storage or distribution), there could be a theoretical risk.
Nonetheless, purified water is not typically considered a primary source of disease transmission under standard conditions.
* B. Grey water: Grey water refers to wastewater generated from domestic activities such as washing dishes, laundry, or bathing, which may contain soap, food particles, and small amounts of organic matter. It is not suitable for drinking due to its potential contaminationwith pathogens (e.g., bacteria, viruses) and chemicals. Grey water is explicitly excluded from potable water standards and poses a significant risk for disease transmission, making it an unsuitable choice for this question.
* C. Potable water: Potable water is water that meets regulatory standards for human consumption, as defined by organizations like the World Health Organization (WHO) or the U.S. Environmental Protection Agency (EPA). It is treated to remove harmful pathogens and contaminants, making it safe for drinking under normal circumstances. However, despite treatment, potable water can still pose a risk for disease transmission if the distribution system is contaminated (e.g., through biofilms, cross- connections, or inadequate maintenance of pipes). Outbreaks of waterborne diseases like Legionnaires' disease or gastrointestinal infections have been linked to potable water systems, especially in healthcare settings. This makes potable water the best answer, as it is suitable for drinking yet can still carry a risk under certain conditions.
* D. Distilled water: Distilled water is produced by boiling water and condensing the steam, which removes most impurities, minerals, and microorganisms. It is highly pure and safe for drinking, often used in medical and laboratory settings. Similar to purified water, the risk of disease transmission is extremely low unless contamination occurs after distillation due to improper handling or storage. Like purified water, it is not typically associated with disease transmission risks in standard use.
The key to this question lies in identifying a water type that is both suitable for drinking and has a documented potential for disease transmission. Potable water fits this criterion because, while it is intended for consumption and meets safety standards, it can still be a vector for disease if the water supply or distribution system is compromised. This is particularly relevant in infection control, where maintaining water safety in healthcare facilities is a critical concern addressed by CBIC guidelines.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which highlights the importance of water safety and the risks of contamination in potable water systems.
CBIC Examination Content Outline, Domain IV: Environment of Care, which includes managing waterborne pathogens (e.g., Legionella) in potable water supplies.


NEW QUESTION # 64
A suspected measles case has been identified in an outpatient clinic without an airborne infection isolation room (AIIR). Which of the following is the BEST course of action?

  • A. Patient should be offered the Measles. Mumps, Rubella (MMR) vaccine
  • B. Staff should don a respirator, gown, and face shield.
  • C. Patient should be masked and placed in a private room with door closed.
  • D. Patient should be sent home

Answer: C

Explanation:
Measles is a highly contagious airborne disease, and the best immediate action in an outpatient clinic without an Airborne Infection Isolation Room (AIIR) is to mask the patient and isolate them in a private room with the door closed.
Why the Other Options Are Incorrect?
* A. Patient should be sent home - While home isolation may be necessary, sending the patient home without proper precautions increases exposure risk.
* B. Staff should don a respirator, gown, and face shield - While N95 respirators are necessary for staff, this does not address patient containment.
* C. Patient should be offered the MMR vaccine - The vaccine does not treat active measles infection and should be given only as post-exposure prophylaxis to susceptible contacts.
CBIC Infection Control Reference
Measles cases in outpatient settings require immediate airborne precautions to prevent transmission.


NEW QUESTION # 65
The BEST roommate selection for a patient with active shingles would be a patient who has had

  • A. treatment with acyclovir
  • B. varicclla zoster immunoglobulin
  • C. a history of herpes simplex.
  • D. varicella vaccine.

Answer: D

Explanation:
A patient with active shingles (herpes zoster) is contagious to individuals who have never had varicella (chickenpox) or the varicella vaccine. The best roommate selection is someone who has received the varicella vaccine, as they are considered immune and not at risk for contracting the virus.
Why the Other Options Are Incorrect?
* B. Treatment with acyclovir - Acyclovir treats herpes zoster but does not prevent transmission to others.
* C. A history of herpes simplex - Prior herpes simplex virus (HSV) infection does not confer immunity to varicella-zoster virus (VZV).
* D. Varicella zoster immunoglobulin (VZIG) - VZIG provides temporary immunity but does not offer long-term protection like the vaccine.
CBIC Infection Control Reference
APIC guidelines recommend placing patients with active shingles in a room with individuals immune to varicella, such as those vaccinated.


NEW QUESTION # 66
A patient with pertussis can be removed from Droplet Precautions after

  • A. the patient has been given pertussis vaccine.
  • B. direct fluorescent antibody and/or culture are negative.
  • C. five days of appropriate antibiotic therapy.
  • D. the paroxysmal stage has ended.

Answer: C

Explanation:
A patient with pertussis (whooping cough) should remain on Droplet Precautions to prevent transmission.
According to APIC guidelines, patients with pertussis can be removed from Droplet Precautions after completing at least five days of appropriate antimicrobial therapy and showing clinical improvement.
Why the Other Options Are Incorrect?
* A. Direct fluorescent antibody and/or culture are negative - Laboratory results may not always detect pertussis early, and false negatives can occur.
* C. The patient has been given pertussis vaccine - The vaccine prevents but does not treat pertussis, and it does not shorten the period of contagiousness.
* D. The paroxysmal stage has ended - The paroxysmal stage (severe coughing fits) can last weeks, but infectiousness decreases with antibiotics.
CBIC Infection Control Reference
According to APIC guidelines, Droplet Precautions should continue until the patient has received at least five days of antimicrobial therapy.


NEW QUESTION # 67
A team was created to determine what has contributed to the recent increase in catheter associated urinary tract infections (CAUTIs). What quality tool should the team use?

  • A. Gap analysis
  • B. Failure mode and effect analysis (FMEA)
  • C. Fishbone diagram
  • D. Plan, do, study, act (PDSA)

Answer: C

Explanation:
The correct answer is B, "Fishbone diagram," as this is the most appropriate quality tool for the team to use when determining what has contributed to the recent increase in catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the fishbone diagram, also known as an Ishikawa or cause-and-effect diagram, is a structured tool used to identify and categorize potential causes of a problem. In this case, the team needs to explore the root causes of the CAUTI increase, which could include factors such as improper catheter insertion techniques, inadequate maintenance, staff training gaps, or environmental issues (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.2 - Analyze surveillance data). The fishbone diagram organizes these causes into categories (e.g., people, process, equipment, environment), facilitating a comprehensive analysis and guiding further investigation or intervention.
Option A (gap analysis) is useful for comparing current performance against a desired standard or benchmark, but it is more suited for identifying deficiencies in existing processes rather than uncovering the specific causes of a recent increase. Option C (plan, do, study, act [PDSA]) is a cyclical quality improvement methodology for testing and implementing changes, which would be relevant after identifying causes and designing interventions, not as the initial tool for root cause analysis. Option D (failure mode and effect analysis [FMEA]) is a proactive risk assessment tool used to predict and mitigate potential failures in a process before they occur, making it less applicable to analyzing an existing increase in CAUTIs.
The use of a fishbone diagram aligns with CBIC's emphasis on using data-driven tools to investigate and address healthcare-associated infections (HAIs) like CAUTIs, supporting the team's goal of pinpointing contributory factors (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.3 - Identify risk factors for healthcare-associated infections). This tool's visual and collaborative nature also fosters team engagement, which is essential for effective problem-solving in infection prevention.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.2 - Analyze surveillance data, 2.3 - Identify risk factors for healthcare-associated infections.


NEW QUESTION # 68
A patient with a non-crusted rash has boon diagnosed with Sarcoptes scabiei. The patient is treated with 5% permethrin and precautions are started. The precautions can be stopped

  • A. 24 hours after effective treatment
  • B. when the bed linen is changed
  • C. 24 hours after the second treatment
  • D. when the treatment cream is applied

Answer: A

Explanation:
ForSarcoptes scabiei(scabies),Contact Precautionsshould remainin place until 24 hours after effective treatment has been completed. The first-line treatment is5% permethrin cream, which is applied to the entire body and left on for8-14 hoursbefore being washed off.
Why the Other Options Are Incorrect?
* A. When the treatment cream is applied- Themite is still presentand infectiousuntil treatment has fully taken effect.
* B. When the bed linen is changed-While changing linens is necessary, it doesnot indicate that the infestation has cleared.
* D. 24 hours after the second treatment- Mostcases require only one treatmentwith permethrin, though severe cases may need a second dose after a week.
CBIC Infection Control Reference
According toAPIC guidelines,Contact Precautions can be discontinued 24 hours after effective treatment has been administered.


NEW QUESTION # 69
A task force formed to focus on Clostridioides difficile infections (CDIs). The topic of the meeting discussed selecting the correct germicidal wipe. What important factor does the infection preventionist review?

  • A. Time the surface remains wet
  • B. Correct disposal of the wipe
  • C. Cost of a case of wipes
  • D. Size of individual wipes

Answer: A

Explanation:
The correct answer is C, "Time the surface remains wet," as this is the most important factor the infection preventionist (IP) should review when selecting a germicidal wipe for controlling Clostridioides difficile infections (CDIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective environmental cleaning is a critical component of infection prevention, particularly for pathogens like C. difficile, which forms hardy spores that are resistant to many disinfectants. The efficacy of a germicidal wipe depends on the contact time-the duration the surface must remain wet with the disinfectant to ensure the killing of C. difficile spores. This is specified by the manufacturer and supported by guidelines from the Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA), which emphasize that the disinfectant must remain wet on the surface for the full recommended contact time (typically 1-10 minutes for sporicidal agents) to achieve the desired level of disinfection (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols).
Option A (cost of a case of wipes) is a practical consideration for budgeting but is secondary to efficacy in infection control, especially for a high-priority pathogen like C. difficile. Option B (size of individual wipes) may affect coverage and convenience but does not directly impact the wipe's ability to eliminate the pathogen. Option D (correct disposal of the wipe) is important for preventing cross-contamination and ensuring compliance with waste management protocols, but it is a procedural step after use and not the primary factor in selecting the wipe.
The IP's review of contact time aligns with CBIC's focus on evidence-based practices to prevent healthcare- associated infections (HAIs). For C. difficile, which is a leading cause of HAIs, selecting a wipe with an appropriate sporicidal agent and ensuring adequate wet contact time is essential to disrupt transmission, particularly in outbreak settings (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019). This factor directly influences the wipe's effectiveness, making it the critical review point for the task force.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.


NEW QUESTION # 70
Which of the following intravenous solutions will MOST likely promote the growth of microorganisms?

  • A. 5% dextrose
  • B. Synthetic amino acids
  • C. 50% hypertonic glucose
  • D. 10% lipid emulsions

Answer: D

Explanation:
10% lipid emulsions are the most likely to promote microbial growth because they provide an ideal environment for bacterial and fungal proliferation, especially Staphylococcus aureus, Pseudomonas aeruginosa, and Candida species. Lipids support rapid bacterial multiplication due to their high nutrient content.
Why the Other Options Are Incorrect?
* A. 50% hypertonic glucose - High glucose concentrations inhibit bacterial growth due to osmotic pressure effects.
* B. 5% dextrose - While it can support some bacterial growth, it is less favorable than lipid emulsions.
* C. Synthetic amino acids - These solutions do not support microbial growth as well as lipid emulsions.
CBIC Infection Control Reference
APIC guidelines confirm that lipid-based solutions support rapid microbial growth and should be handled with strict aseptic technique.


NEW QUESTION # 71
Which performance improvement model should the infection preventionist use to aid in the evaluation of the infection control plan?

  • A. Failure mode and effects analysis
  • B. Root Cause Analysis
  • C. Plan, Do, Study, Act
  • D. Six Sigma

Answer: C

Explanation:
The Plan, Do, Study, Act (PDSA) model is a widely used performance improvement tool in infection prevention. It focuses on continuous quality improvement through planning, implementing, analyzing data, and making adjustments. This model aligns with infection control program evaluations and The Joint Commission's infection prevention and control standards.
Why the Other Options Are Incorrect?
* A. Six Sigma - A data-driven process improvement method but not as commonly used in infection control as PDSA.
* B. Failure Mode and Effects Analysis (FMEA) - Used to identify risks before implementation, rather than ongoing evaluation.
* D. Root Cause Analysis (RCA) - Used to analyze failures after they occur, rather than guiding continuous improvement.
CBIC Infection Control Reference
The PDSA cycle is a recognized model for evaluating and improving infection control plans.


NEW QUESTION # 72
The annual report for Infection Prevention shows a dramatic decrease in urinary catheter days, a decrease in the catheter utilization ratio, and a slight decrease in the number of catheter-associated urinary tract infections (CAUTIs). The report does not show an increase in the overall rate of CAUTI. How would the infection preventionist explain this to the administration?

  • A. The rate is incorrect and needs to be recalculated.
  • B. The rate may be higher if the denominator is very small.
  • C. The rate is not affected by the number of catheter days.
  • D. Decreasing catheter days will not have an effect on decreasing CAUTI.

Answer: B

Explanation:
The correct answer is B, "The rate may be higher if the denominator is very small," as this provides the most plausible explanation for the observed data in the annual report. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the CAUTI rate is calculated as the number of CAUTIs per 1,000 catheter days, where catheter days serve as the denominator. The report indicates a dramatic decrease in urinary catheter days and a slight decrease in the number of CAUTIs, yet the overall CAUTI rate has not increased. This discrepancy can occur if the denominator (catheter days) becomes very small, which can inflate or destabilize the rate, potentially masking an actual increase in the infection risk per catheter day (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.2 - Analyze surveillance data). A smaller denominator amplifies the impact of even a slight change in the number of infections, suggesting that the rate may be higher than expected or less reliable, necessitating further investigation.
Option A (the rate is incorrect and needs to be recalculated) assumes an error in the calculation without evidence, which is less specific than the denominator effect explanation. Option C (the rate is not affected by the number of catheter days) is incorrect because the CAUTI rate is directly influenced by the number of catheter days as the denominator; a decrease in catheter days should typically lower the rate if infections decrease proportionally, but the lack of an increase here suggests a calculation or interpretation issue. Option D (decreasing catheter days will not have an effect on decreasing CAUTI) contradicts evidence-based practice, as reducing catheter days is a proven strategy to lower CAUTI incidence, though the rate's stability here indicates a potential statistical artifact.
The explanation focusing on the denominator aligns with CBIC's emphasis on accurate surveillance and data analysis to guide infection prevention strategies, allowing the infection preventionist to advise administration on the need to review data trends or adjust monitoring methods (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies). This insight can prompt a deeper analysis to ensure the CAUTI rate reflects true infection risk.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.2 - Analyze surveillance data, 2.5 - Use data to guide infection prevention and control strategies.


NEW QUESTION # 73
Which water type is suitable for drinking yet may still be a risk for disease transmission?

  • A. Grey water
  • B. Potable water
  • C. Purified water
  • D. Distilled water

Answer: B

Explanation:
To determine which water type is suitable for drinking yet may still pose a risk for disease transmission, we need to evaluate each option based on its definition, treatment process, and potential for contamination, aligning with infection control principles as outlined by the Certification Board of Infection Control and Epidemiology (CBIC).
* A. Purified water: Purified water undergoes a rigorous treatment process (e.g., reverse osmosis, distillation, or deionization) to remove impurities, contaminants, and microorganisms. This results in water that is generally safe for drinking and has a very low risk of disease transmission when properly handled and stored. However, if the purification process is compromised or if contamination occurs post-purification (e.g., due to improper storage or distribution), there could be a theoretical risk.
Nonetheless, purified water is not typically considered a primary source of disease transmission under standard conditions.
* B. Grey water: Grey water refers to wastewater generated from domestic activities such as washing dishes, laundry, or bathing, which may contain soap, food particles, and small amounts of organic matter. It is not suitable for drinking due to its potential contamination with pathogens (e.g., bacteria, viruses) and chemicals. Grey water is explicitly excluded from potable water standards and poses a significant risk for disease transmission, making it an unsuitable choice for this question.
* C. Potable water: Potable water is water that meets regulatory standards for human consumption, as defined by organizations like the World Health Organization (WHO) or the U.S. Environmental Protection Agency (EPA). It is treated to remove harmful pathogens and contaminants, making it safe for drinking under normal circumstances. However, despite treatment, potable water can still pose a risk for disease transmission if the distribution system is contaminated (e.g., through biofilms, cross- connections, or inadequate maintenance of pipes). Outbreaks of waterborne diseases like Legionnaires' disease or gastrointestinal infections have been linked to potable water systems, especially in healthcare settings. This makes potable water the best answer, as it is suitable for drinking yet can still carry a risk under certain conditions.
* D. Distilled water: Distilled water is produced by boiling water and condensing the steam, which removes most impurities, minerals, and microorganisms. It is highly pure and safe for drinking, often used in medical and laboratory settings. Similar to purified water, the risk of disease transmission is extremely low unless contamination occurs after distillation due to improper handling or storage. Like purified water, it is not typically associated with disease transmission risks in standard use.
The key to this question lies in identifying a water type that is both suitable for drinking and has a documented potential for disease transmission. Potable water fits this criterion because, while it is intended for consumption and meets safety standards, it can still be a vector for disease if the water supply or distribution system is compromised. This is particularly relevant in infection control, where maintaining water safety in healthcare facilities is a critical concern addressed by CBIC guidelines.
References:
* CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which highlights the importance of water safety and the risks of contamination in potable water systems.
* CBIC Examination Content Outline, Domain IV: Environment of Care, which includes managing waterborne pathogens (e.g., Legionella) in potable water supplies.


NEW QUESTION # 74
When evaluating environmental cleaning and disinfectant products as a part of the product evaluation committee, which of the following is responsible for providing information regarding clinical trials?

  • A. Clinical representatives
  • B. Manufacturer representatives
  • C. Infection Preventionist
  • D. Environmental Services

Answer: B

Explanation:
The correct answer is D, "Manufacturer representatives," as they are responsible for providing information regarding clinical trials when evaluating environmental cleaning and disinfectant products as part of the product evaluation committee. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, manufacturers are the primary source of data on the efficacy, safety, and performance of their products, including clinical trial results that demonstrate the disinfectant's ability to reduce microbial load or prevent healthcare-associated infections (HAIs) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols).
This information is critical for the committee to assess whether the product meets regulatory standards (e.g., EPA registration) and aligns with infection prevention goals, and it is typically supported by documentation such as peer-reviewed studies or trial data provided by the manufacturer.
Option A (Infection Preventionist) plays a key role in evaluating the product's fit within infection control practices and may contribute expertise or conduct internal assessments, but they are not responsible for providing clinical trial data, which originates from the manufacturer. Option B (Clinical representatives) can offer insights into clinical usage and outcomes but rely on manufacturer data for trial evidence rather than generating it. Option C (Environmental Services) focuses on the practical application and cleaning processes but lacks the authority or resources to conduct or provide clinical trial information.
The reliance on manufacturer representatives aligns with CBIC's emphasis on evidence-based decision- making in product selection, ensuring that the product evaluation committee bases its choices on robust, manufacturer-supplied clinical data (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies).
This approach supports the safe and effective implementation of environmental cleaning products in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies; Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols.


NEW QUESTION # 75
A 2-yoar-old girl is admitted with a fractured tibia. At birth, she was diagnosed with congenital cytomegalovirus (CMV). Which of the following barrier precautions is appropriate for healthcare personnel caring for her?

  • A. Wear gloves when handling body fluids
  • B. No barrier precautions are needed
  • C. Wear masks and gloves
  • D. Use gowns, masks, gloves, and a private room

Answer: A

Explanation:
Standard Precautions are sufficient for congenital cytomegalovirus (CMV), which means that gloves should be used when handling body fluids. CMV is primarily transmitted via direct contact with saliva, urine, or blood.
Why the Other Options Are Incorrect?
* A. Wear masks and gloves - Masks are not necessary unless performing high-risk aerosol- generating procedures.
* C. No barrier precautions are needed - Gloves are required when handling bodily fluids to prevent transmission.
* D. Use gowns, masks, gloves, and a private room - CMV does not require Contact or Airborne Precautions.
CBIC Infection Control Reference
APIC guidelines state that CMV transmission is prevented using Standard Precautions, primarily with glove use for body fluid contact.


NEW QUESTION # 76
The expectation to call out or speak up when an infection prevention lapse is observed is an example of

  • A. implementation of human factors.
  • B. a blaming and shaming safety culture.
  • C. a safety culture with reciprocal accountability.
  • D. honest disclosure of a safety event.

Answer: C

Explanation:
A safety culture withreciprocal accountabilityemphasizes mutual responsibility for maintaining safe practices, encouraging staff at all levels to "speak up" or "stop the line" when they observe risky practices.
This concept reflects a learning organization and a just culture that supports open communication and proactive risk mitigation.
* According to theAPIC Text, a strong safety culture is described as one where:
"The leadership can expect staff members to call out or stop the line when they see risk, and staff can expect leadership to listen and act." This dynamic reflects reciprocal accountability.
* Other options are less accurate:
* A. Human factorsrefer to system design, not behavioral accountability.
* B. Honest disclosure of a safety eventis about post-event transparency, not real-time intervention.
* C. A blaming and shaming cultureis antithetical to safety culture principles.
References:
APIC Text, 4th Edition, Chapter 18 - Patient Safety


NEW QUESTION # 77
A surgical team is performing a liver transplant. Which of the following represents the HIGHEST risk for transmission of a healthcare-associated infection?

  • A. Using alcohol-based hand rub instead of surgical scrub.
  • B. Failure to change surgical gloves after contamination.
  • C. Airflow disruption due to personnel movement.
  • D. Delayed administration of preoperative antibiotics.

Answer: B

Explanation:
* Glove Contamination and SSI Risk:
* Failure to change contaminated gloves increases the risk of surgical site infections (SSIs).
* Double-gloving with an outer glove change reduces contamination.
* Why Other Options Are Incorrect:
* B. Alcohol-based hand rubs: Are FDA-approved alternatives to traditional scrubs and effective.
* C. Delayed antibiotics: Increases infection risk, but immediate correction reduces harm.
* D. Airflow disruption: Can increase SSI risk, but glove contamination poses a more direct threat.
CBIC Infection Control References:
* APIC-JCR Workbook, "Surgical Infection Prevention," Chapter 6.


NEW QUESTION # 78
A hospital is experiencing an increase in vancomycin-resistant Enterococcus (VRE) infections in the hematology-oncology unit. Which of the following interventions is MOST effective in halting the spread of VRE in this high-risk setting?

  • A. Restricting the use of vancomycin for all patients in the hospital.
  • B. Screening all patients on admission and placing positive patients in isolation.
  • C. Conducting environmental sampling for VRE contamination weekly.
  • D. Implementing a hand hygiene compliance audit and feedback system.

Answer: D

Explanation:
Comprehensive and Detailed In-Depth Explanation:
Hand hygiene remains the single most effective intervention to prevent the spread of vancomycin-resistant Enterococcus (VRE) in healthcare settings. Implementing an audit and feedback system significantly improves compliance and reduces VRE transmission.
Step-by-Step Justification:
* Hand Hygiene Compliance Audit and Feedback (Best Strategy)
* Studies show that poor hand hygiene is the primary mode of VRE transmission in hospitals.
* Implementing real-time auditing with feedback ensures sustained compliance and helps identify weak areas.
* Why Other Options Are Incorrect:
* A. Screening all patients and isolating VRE-positive patients:
* While screening helps identify carriers, contact precautions alone are not sufficient without strong hand hygiene enforcement.
* B. Restricting vancomycin use:
* While antimicrobial stewardship is crucial, vancomycin use alone does not drive VRE outbreaks-poor infection control practices do.
* D. Conducting environmental sampling weekly:
* Routine sampling is not necessary; immediate terminal disinfection and improved hand hygiene are more effective.
CBIC Infection Control References:
* APIC Text, "VRE Prevention and Hand Hygiene," Chapter 11.
* APIC-JCR Workbook, "Antimicrobial Resistance and Infection Control Measures," Chapter 7.


NEW QUESTION # 79
A patient has an oral temperature of 101° F (38.33 C). Erythema and tenderness arc noted at the central line site. Blood samples are submitted for culture and intravenous vancomycin is ordered. This is an example of which of the following forms of antibiotic treatment?

  • A. Empiric
  • B. Broad spectrum
  • C. Prophylactic
  • D. Experimental

Answer: A

Explanation:
Empiric antibiotic therapy is the immediate initiation of antibiotics based on clinical judgment before laboratory confirmation of an infection. In this case, the presence of fever, erythema, and tenderness at the central line site suggests a possible bloodstream infection, prompting empiric treatment with vancomycin.
Step-by-Step Justification:
* Initiation Before Lab Confirmation:
* Empiric therapy starts treatment based on symptoms while awaiting culture results.
* Prevents Complications:
* Delayed treatment in central line-associated bloodstream infections (CLABSI) can lead to sepsis.
* Common in High-Risk Situations:
* Empiric treatment is used in cases where waiting for lab results could worsen the patient's condition.
Why Other Options Are Incorrect:
* B. Prophylactic:
* Prophylactic antibiotics are given to prevent infection, not to treat an existing one.
* C. Experimental:
* Experimental treatment refers to clinical trials or unproven therapies, which does not apply here.
* D. Broad spectrum:
* Broad-spectrum antibiotics cover multiple bacteria, but empiric therapy may be narrow- spectrum based on suspected pathogens.
CBIC Infection Control References:
* APIC Text, Chapter on Antimicrobial Stewardship and Empiric Therapy.


NEW QUESTION # 80
Hand-hygiene audits in a long-term care facility have demonstrated consistently low levels of staff compliance. An infection preventionist is planning an education program to try to improve hand-hygiene rates. Regarding assessment of the effectiveness of the education program, which of the following is true?

  • A. A summative evaluation will accurately reflect the extent to which participants will change their hand- hygiene practices.
  • B. Repeated observations of staff will be required in order to demonstrate that the program has been effective.
  • C. A change between pre- and post-test scores correlates well with the expected change in hand-hygiene compliance.
  • D. An evaluation of the program is not required if the program is mandatory.

Answer: B

Explanation:
The correct answer is B, "Repeated observations of staff will be required in order to demonstrate that the program has been effective," as this statement is true regarding the assessment of the effectiveness of the education program. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, evaluating the impact of an education program on hand-hygiene compliance in a long-term care facility requires ongoing monitoring to assess sustained behavior change. Repeated observations provide direct evidence of staff adherence to hand-hygiene protocols over time, allowing the infection preventionist (IP) to measure the program's effectiveness beyond initial training (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). This method aligns with the World Health Organization (WHO) and CDC recommendations for hand-hygiene improvement, which emphasize continuous auditing to ensure lasting improvements in compliance rates.
Option A (a summative evaluation will accurately reflect the extent to which participants will change their hand-hygiene practices) is incorrect because a summative evaluation, typically conducted at the end of a program, assesses overall outcomes but does not predict future behavior changes or account for long-term compliance, which is critical in this context. Option C (a change between pre- and post-test scores correlates well with the expected change in hand-hygiene compliance) is misleading; while pre- and post-tests can measure knowledge gain, they do not reliably correlate with actual practice changes, as knowledge does not always translate to behavior without observation. Option D (an evaluation of the program is not required if the program is mandatory) is false, as mandatory programs still require evaluation to verify effectiveness, especially when addressing low compliance, per CBIC and quality improvement standards.
The focus on repeated observations aligns with CBIC's emphasis on data-driven assessment to improve infection prevention practices, ensuring that the education program leads to sustained hand-hygiene improvements and reduces healthcare-associated infections (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.4 - Evaluate the effectiveness of infection prevention and control interventions).
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 - Evaluate the effectiveness of infection prevention and control interventions; Domain IV:
Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs. WHO Guidelines on Hand Hygiene in Health Care, 2009. CDC Hand Hygiene in Healthcare Settings, 2019.


NEW QUESTION # 81
The cleaning and disinfection process that is appropriate for a particular surgical instrument depends on

  • A. the device manufacturer's written instructions for use.
  • B. the policies of the sterile processing department.
  • C. all surgical instruments are cleaned and sterilized in the same manner.
  • D. instruments contaminated with blood must be bleach cleaned first.

Answer: A

Explanation:
The correct answer is C, "the device manufacturer's written instructions for use," as this is the factor that determines the appropriate cleaning and disinfection process for a particular surgical instrument. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of surgical instruments must follow the specific instructions provided by the device manufacturer to ensure safety and efficacy. These instructions account for the instrument's material, design, and intended use, specifying the appropriate cleaning agents, disinfection methods, sterilization techniques, and contact times to prevent damage and ensure the elimination of pathogens (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This is also mandated by regulatory standards, such as those from the Food and Drug Administration (FDA) and the Association for the Advancement of Medical Instrumentation (AAMI), which require adherence to manufacturer guidelines to maintain device integrity and patient safety.
Option A (all surgical instruments are cleaned and sterilized in the same manner) is incorrect because different instruments have unique characteristics (e.g., materials like stainless steel vs. delicate optics), necessitating tailored reprocessing methods rather than a one-size-fits-all approach. Option B (instruments contaminated with blood must be bleach cleaned first) is a misconception; while blood contamination requires thorough cleaning, bleach is not universally appropriate and may damage certain instruments unless specified by the manufacturer. Option D (the policies of the sterile processing department) may guide internal procedures but must be based on and subordinate to the manufacturer's instructions to ensure compliance and effectiveness.
The emphasis on manufacturer instructions aligns with CBIC's focus on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) and protect patients (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). Deviating from these guidelines can lead to inadequate sterilization or instrument damage, increasing infection risks.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 - Ensure safe reprocessing of medical equipment, 3.5 - Evaluate the environment for infection risks. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.


NEW QUESTION # 82
During the last week in June, an emergency department log reveals numerous cases of profuse watery diarrhea in individuals 74 years of age and older. During the same time period, four immunocompromised patients were admitted with possible Cryptosporidium. Which of the following actions should the infection preventionist take FIKST?

  • A. Contact the laboratory to confirm stool identification results
  • B. Form a tentative hypothesis about the potential reservoir for this outbreak
  • C. Characterize the outbreak by person, place, and time
  • D. Increase surveillance facility wide for additional cases

Answer: C

Explanation:
When an outbreak of infectious disease is suspected, the first step is to conduct an epidemiologic investigation. This begins with characterizing the outbreak by person, place, and time to establish patterns and trends. This approach, known as descriptive epidemiology, provides critical insights into potential sources and transmission patterns.
Step-by-Step Justification:
* Identify Cases and Patterns:
* The infection preventionist should analyze patient demographics (person), locations of cases (place), and onset of symptoms (time). This helps in defining the outbreak scope and potential exposure sources.
* Create an Epidemic Curve:
* An epidemic curve helps determine whether the outbreak is a point-source or propagated event.
This can indicate whether the infection is spreading person-to-person or originating from a common source.
* Compare with Baseline Data:
* Reviewing historical data ensures that the observed cases exceed the expected norm, confirming an outbreak.
* Guide Further Investigation:
* Establishing basic epidemiologic patterns guides subsequent actions, such as laboratory testing, environmental sampling, and surveillance.
Why Other Options Are Incorrect:
* B. Increase surveillance facility-wide for additional cases:
* While enhanced surveillance is important, it should follow the initial characterization of the outbreak. Surveillance without a defined case profile may lead to misclassification and misinterpretation.
* C. Contact the laboratory to confirm stool identification results:
* Confirming lab results is essential but comes after defining the outbreak's characteristics. Without an epidemiologic link, testing may yield results that are difficult to interpret.
* D. Form a tentative hypothesis about the potential reservoir for this outbreak:
* Hypothesis generation occurs after sufficient epidemiologic data have been collected. Jumping to conclusions without characterization may result in incorrect assumptions and ineffective control measures.
CBIC Infection Control References:
* APIC Text, "Outbreak Investigations," Epidemiology, Surveillance, Performance, and Patient Safety Measures.
* APIC/JCR Infection Prevention and Control Workbook, Chapter 4, Surveillance Program.
* APIC Text, "Investigating Infectious Disease Outbreaks," Guidelines for Epidemic Curve Analysis.


NEW QUESTION # 83
What is a characteristic of immediate-use steam sterilization?

  • A. Performed in emergencies where cleaning is the most critical step.
  • B. Can be used for the following surgery if properly stored.
  • C. Alternative to purchasing expensive instrument sets.
  • D. Substitute for maintaining sufficient amounts of sterile instruments.

Answer: D

Explanation:
The correct answer is C, "Substitute for maintaining sufficient amounts of sterile instruments," as this is a characteristic of immediate-use steam sterilization (IUSS). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, IUSS, formerly known as flash sterilization, is a process designed to rapidly sterilize items that are needed urgently when pre-sterilized inventory is unavailable or insufficient. It serves as a temporary solution to address gaps in sterile instrument availability, such as during unexpected surges in surgical demand or equipment shortages, provided strict protocols are followed (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). However, IUSS is not a routine practice and should be minimized due to its limitations, including the lack of immediate biologic indicator results.
Option A (alternative to purchasing expensive instrument sets) is incorrect because IUSS is not intended as a cost-saving measure or a replacement for acquiring necessary equipment; it is a contingency process. Option B (can be used for the following surgery if properly stored) is misleading, as IUSS items are intended for immediate use and not for storage or use in subsequent procedures, which requires standard sterilization cycles with proper packaging and validation. Option D (performed in emergencies where cleaning is the most critical step) overemphasizes cleaning and mischaracterizes IUSS; while cleaning is a critical initial step, the process is defined by its rapid sterilization for emergency use, not solely by cleaning priority.
The characteristic of substituting for insufficient sterile instruments aligns with CBIC's focus on ensuring safe reprocessing practices while acknowledging the practical challenges in healthcare settings (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This is supported by AAMI ST79, which outlines IUSS as a last-resort measure to maintain surgical readiness (AAMI ST79:2017).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 - Ensure safe reprocessing of medical equipment, 3.5 - Evaluate the environment for infection risks. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.


NEW QUESTION # 84
Which of the following activities will BEST prepare a newly hired infection preventionist to present information at the facility's orientation program?

  • A. Administering tuberculin skin tests to orientees
  • B. Observing other departments' orientation presentations
  • C. Reviewing principles of adult learning
  • D. Meeting with the facility's leadership

Answer: C

Explanation:
The correct answer is C, "Reviewing principles of adult learning," as this activity will best prepare a newly hired infection preventionist to present information at the facility's orientation program. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective education delivery, especially for healthcare professionals during orientation, relies on understanding adult learning principles (e.
g., andragogy), which emphasize learner-centered approaches, relevance to practice, and active participation.
Reviewing these principles equips the infection preventionist (IP) to design and deliver content that addresses the specific needs, experiences, and motivations of the audience-such as new staff learning infection control protocols-enhancing engagement and retention (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.1 - Develop and implement educational programs). This preparation ensures the presentation is tailored, impactful, and aligned with the goal of promoting infection prevention behaviors.
Option A (observing other departments' orientation presentations) can provide insights into presentation styles or facility norms, but it is less focused on the IP's specific educational role and may not address the unique content of infection prevention. Option B (meeting with the facility's leadership) is valuable for understanding organizational priorities and gaining support, but it is more about collaboration and context- setting rather than direct preparation for presenting educational material. Option D (administering tuberculin skin tests to orientees) is a clinical task related to TB screening, not a preparatory activity for designing or delivering an educational presentation.
The focus on reviewing adult learning principles aligns with CBIC's emphasis on evidence-based education strategies to improve infection control practices among healthcare personnel (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs).
This approach enables the IP to effectively communicate critical information, such as hand hygiene or isolation protocols, during the orientation program.
References: CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competencies 4.1 - Develop and implement educational programs, 4.2 - Evaluate the effectiveness of educational programs.


NEW QUESTION # 85
......

Pass Your CIC Exam Easily With 100% Exam Passing Guarantee: https://www.realexamfree.com/CIC-real-exam-dumps.html

CIC Dumps are Available for Instant Access: https://drive.google.com/open?id=1mOtxj-Ytk4X6m3bHQhkoQgDPRzRB98xf